John Scandurra

Oscient Pharmaceuticals Corp. is a biopharmaceutical company that sells and markets products to community-based primary care physicians through its primary care sales force in the United States. It markets two products namely, ANTARA fenofibrate capsules, a cardiovascular product and FACTIVE gemifloxacin mesylate tablets, a fluoroquinolone antibiotic. It also has late-stage antibiotic candidate, Ramoplanin for the treatment of clostridium difficile-associated disease. The company was founded on May 09, 1961 and is headquartered in Waltham, MA.

Heart Leaflet Technologies, Inc. develops heart leaflet repair systems. It provides percutaneous aortic heart valves that can be used to repair stenosed or calcified valves without the use of open-heart surgery. The company was founded by Dan W. Gladney and Robert Foster Wilson in 2002 and is headquartered in Maple Grove, MN.

Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC.

Augmenix, Inc. develops hydrogel technology to improve outcomes in radiation oncology and surgery. Its products include TraceIT Tissue Marker and SpaceOAR System, which is an absorbable hydrogel spacer that reduces radiation injury to the rectal wall in men undergoing prostate radiotherapy. The company was founded by Amarpreet S. Sawhney in 2008 and is headquartered in Bedford, MA.

DGIMED Ortho, Inc. manufactures medical devices. The private company is based in Minnetonka, MN. The company was founded by Dan W. Gladney.

Cardialen, Inc. develops medical devices. It offers pain-free cardio version therapy for atrial fibrillation (AF) using low-energy implantable atrial cardioverters. The firm develops and commercializes these as an independent specialist, to address major needs in atrial fibrillation management, achieve improved outcomes and reduce the risk of stroke, heart failure and high healthcare costs associated with atrial fibrillation. The company's products comprise implantable low-energy pain-free atrial cardioverters and cardiac leads and defibrillator equipment. Its products are used for the treatment of atrial and ventricular arrhythmias. Cardialen was founded in 2008 by D. Graeme Thomas, Randy H. Weiss and Igor R. Efimov and is headquartered in St. Louis, MO.

Lantos Technologies, Inc. develops intra-aural 3D ear scanning systems for the custom earpiece market. Its technology enables audiologists to eliminate the uncomfortable, messy, and error-prone technique that used to generate impressions of the ear canal. The firm provides 3D scanner that measures ear canal shape and tissue compliance to produce a map of the ear canal. It also offers noise protection devices for military and industrial markets, and consumer audio earphones. The company is headquartered in Wilmington, MA.

nVision Medical Corp. operates as a venture-backed medical device company. It develops a technology that can be used in the office of the gynecologist to diagnose the cause of infertility as well as ovarian cancer. The company was founded by Surbhi Sarna in January 2012 and is headquartered in San Francisco, CA.

Foldax, Inc. develops synthetic heart valves for delivering non-thrombogenic aortic and mitral valves. The company is headquartered in Salt Lake City, UT.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA.

ACIST Medical Systems, Inc. provides technology for contrast imaging system in the fields of cardiology and radiology. The company was founded by Robert F. Wilson in 1991 and is located in Eden Prairie, MN.

Norwest Equity Partners is a private equity firm, a subsidiary of Norwest Partners founded in 1961 by John E. Lindahl. The firm is headquartered in Minneapolis, Minnesota.

Catalyst Health Ventures (Catalyst Health Ventures) is a venture capital firm founded in 2008 by Darshana Zaveri and Joshua S Phillips. The firm is Headquartered in Boston, Massachusetts.

New England Venture Capital Association, Inc. is a non-profit organization which operates as a catalyst, and advocate, and a resource for the innovation economy. The company is headquartered in Cambridge, MA.

Abbott Medical Canada Co. manufactures global medical device dedicated to transforming the treatment for expensive epidemic diseases. It provides heart failure management, electrophysiology, cardiac rhythm management, structural heart, vascular, and neuromodulation products. The company was founded on January 3, 1988 and is headquartered in Mississauga, Canada.

Broadview Ventures, Inc. (Broadview Ventures) is a venture capital firm founded in 2008. The firm is headquartered in Boston, Massachusetts.

Rad Biomed Accelerator Ltd. (Rad Biomed Accelerator) is a venture capital subsidiary of RAD-Bynet Group founded by Yehuda Zisapel and Nava Zisapel in 1992. The firm is headquartered in Tel Aviv, Israel.

Vascular Graft Solutions Ltd. develops a special device to reduce graft failure rate in order to prevent re-do CABG (Coronaly artery bypass grafting) operation and other secondary interventions in coronary patients. The firm has developed the VEST, a novel Venous External STent for vein grafts. The device is kink-resistant external stent which is deployed over the entire vein graft without interfering with or changing the normal course of the CABG procedure. The company was founded by Eyal Orion in 2009 and is headquartered in Tel Aviv, Israel.

Xeltis AG develops medical devices to transform standards of care in heart valve replacement and vascular surgery. It develops fully bio absorbable synthetic heart valves and vascular grafts intended to enable for the first time the spontaneous growth of natural, healthy valves and vessels. Its medical device platform comprises bioabsorbable heart valves and blood vessels, designed to enable Endogenous Tissue Restoration (ETR), the natural restoration of the complex body part they replace upon implantation. The company was founded by Martijn Cox, Laurent Grandidier and Simon P. Hoerstrup in 2006 and is headquartered in Zurich, Switzerland.

DailyFeats, Inc. engages in the provision of a health-as-a-service platform. It offers an end-to-end operating system for benefits that includes a marketplace, a comprehensive benefits administration system, and a mobile platform where employees access everything benefits-related, navigate the healthcare system, and manage their health and wealth. The company was founded by Veer Gidwaney and Vinay Gidwaney on June 26, 2008 and is headquartered in Boston, MA.

Xeraya Capital Sdn. Bhd. (Xeraya Capital) is a venture capital firm founded in 2006 by Amirul Fares Wan Zahir. The firm is headquartered in Kuala Lumpur, Malaysia.

PanTher Therapeutics, Inc. provides health care services for the treatment of inoperable locally advanced solid tumors. The firm designed its delivery method to eliminate the toxicity and debilitating side effects that chemo agents can produce when delivered systemically through traditional IV or oral administration. The company was founded by Laura Indolfi, Elazer R. Edelman and David T. Ting in May 2014 is headquartered in Cambridge, MA.

FineHeart SA manufactures medical devices for cardiovascular space. It offers wirelessly powered and fully-implantable mechanical circulatory support device. The company was founded by Stéphane Garrigue and Philippe Ritter on January 13, 2010 and is headquartered in Pessac, France.

Adient Medical, Inc. develops and manufactures absorbable medical devices. It offers an absorbable vascular filter for the prevention of pulmonary embolism. The company was founded in 2012 and is headquartered in Pearland, TX.

MIVI Neuroscience, Inc. focuses on developing and commercializing clinical solutions for neurointerventional procedures. The firm provides physicians with devices that improve patient outcomes by reducing complications, shortening procedure times and expanding treatment to more patients. The company is headquartered in Eden Prairie, CA.

Alleviant Medical, Inc. operates as a medical device company, which is developing potential therapies for congestive heart failure. The company was founded by Christopher Alex Arevalos, Albertien Greijdanus, Avni Patel and Jacob Kriegel in February 2017 and is headquartered in Austin, TX.

Instill Srl engages in software development and automation activities. It provides solutions for statistical analysis, machine learning and big data; conversion marketing, search engine optimization, and performance marketing; web development; and design thinking. The company was founded by Massimo Monzio Compagnoni, Filippo Bernasconi, Paolo Meola, and Federico Sordillo on January 30, 2015 and is headquartered in Milan, Italy.

AtaCor Medical, Inc. develops cardiac medical devices. The firm offers AtaCor pacing system. The company was founded by Rick Sanghera, Alan Marcovecchio, and Sean McGeehan in 2014 and is headquartered in San Clemente, CA.

Avive Solutions, Inc. operates as a healthcare technology firm. It develops a next generation automated external defibrillator and software solutions to help increase survival rates from Sudden Cardiac Arrest. The company was founded by Rory Beyer, Sameer Jafri, and Moseley Andrews in 2017 and is headquartered in San Francisco, CA.

Conformal Medical, Inc. operates as a medical company that develops devices to prevent stroke in patient with non-valvular atrial fibrillation. The company was founded by Aaron V. Kaplan and Andy H. Levine in 2016 and is headquartered in Nashua, NH.

Rejoni, Inc. engages in the provision of biotechnology services. It focuses on developing products that improve the outcomes of minimally invasive and other gynecological surgical procedures. The company was founded in June 2020 and is headquartered in Bedford, MA.

RapidPulse, Inc. is a medical device company that specializes in developing minimally invasive vascular products for ischemic stroke. The company is based in Miami, FL. The company is focused on advancing the development of the RapidPulse™ cyclic aspiration system, which includes a novel aspiration pump to allow rapid and consistent removal of blood clots from the brain. RapidPulse is a spinout of Syntheon LLC, a medical device incubator dedicated to developing innovative products in the medical device industry. The CEO of the company is Sean McBrayer.

Vectorious Medical Technologies Ltd. develops cardiac monitoring system for patients suffering from congestive heart failure. Its system implements a novel approach to long-term, implant-based hemodynamic monitoring that leverages state-of-the-art technologies in the areas of miniature sensing and wireless communications. The company was founded in November by Oren Goldshtein, Eyal Orion and Ronny Winstein 2011 and is headquartered in Tel Aviv, Israel.